The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity.
D016604:Aflatoxin B1; D000348:Aflatoxins / Q000494:pharmacology; D000818:Animals; D001564:Benzo(a)pyrene; D001580:Benzopyrenes / Q000494:pharmacology; D001711:Biotransformation; D004128:Dimethylnitrosamine / Q000378:metabolism* / Q000494:pharmacology; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism*; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009152:Mutagenicity Tests; D009154:Mutation; D051381:Rats; D012486:Salmonella typhimurium / Q000187:drug effects
D000348:Aflatoxins; D001580:Benzopyrenes; D008996:Monoamine Oxidase Inhibitors; D001564:Benzo(a)pyrene; D016604:Aflatoxin B1; D008995:Monoamine Oxidase; D004128:Dimethylnitrosamine